We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Comply with good manufacturing practice (GMP) and good distribution practice (GDP), and prepare for an inspection.
Information on MHRA's enforcement duties and how to report a non-compliant medical device.
Public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended.
The tighter controls being introduced to minimise risk of overuse and or addiction of painkillers containing codeine or dihydrocodeine.
People are urged to seek advice from healthcare professionals if they feel they have become dependent on or addicted to codeine linctus.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hall…
An overview of the process including submitting or fast-tracking an application, naming your medicine and paying fees.
Find drug safety updates issued by MHRA
Systemic fluoroquinolones must now only be prescribed when other commonly recommended antibiotics are inappropriate. This follows a review by the MHRA which looked at the effectiveness of current measures to reduce the ident…
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
Funding of £85 million will be announced at a global event to support the international community in tackling the growing threat of antimicrobial resistance.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Quinine should only be considered when cramps cause regular disruption of sleep.
Information about new applications, post-licensing, advertising, product information and fees.
Fake, potentially harmful Ozempic and Saxenda pens have been found in the UK: you should only access these medicines via a medical prescription.
Report a problem ('adverse incident') with a medical device or medicine to MHRA using the Yellow Card Scheme
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
How to package medicines for sale and what information you must provide to consumers and healthcare professionals.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).